Industry News

Industry News

MEMBER NEWS
Kuehne + Nagel breaks ground for new pharma / healthcare facility
Aug 31, 2016 -
Mississauga / Ontario, August 25, 2016 – Kuehne + Nagel, one of the leading global logistics companies, broke ground on its new pharmaceutical/healthcare logistics centre in Mississauga. The ceremony was attended by Bonnie Crombie, Mayor of Mississauga; Philip King, President of Orlando Corporation; Bob Mihok, President and CEO of Kuehne + Nagel North America; Jamie Wood, President of Kuehne + Nagel Canada; as well as Kuehne + Nagel local executives and staff.
view more
 
INDUSTRY NEWS
Registration is Open for the HDA 2017 Distribution Management Conference and Expo
Aug 31, 2016 -
view more
 
Express Scripts Launches Diabetes Care Value Program?, Guaranteeing More Affordable, Higher-Quality Diabetes Care
Aug 31, 2016 - Le Lezard (EN)
view more
 
SHYFT Analytics Raises $12.5 Million in New Funding From Global Healthcare and Technology Leaders, Led by McKesson Ventures and Medidata Solutions
Aug 30, 2016 - The Canadian Business Journal
view more
 
Valeant accused of racketeering in class-action lawsuit from N.Y. health funds
Aug 29, 2016 - Truro Daily News
view more
 
Epipen maker to launch cheaper, generic version in U.S.
Aug 29, 2016 - CBC.ca
view more
 
Mylan to Launch First Generic to EpiPen® Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand Product
Aug 29, 2016 - Le Lezard (EN)
view more
 
 
Roche receives FDA Emergency Use Authorization for Zika PCR test
Aug 29, 2016 - Le Lezard (EN)
view more
 
Firefighters seeking OK to carry overdose treatment
Aug 27, 2016 - Prince George Citizen
view more
 
Mylan deepens discount on some EpiPen sales in U.S. after criticism
Aug 25, 2016 - CBC.ca
view more
 
Senators question price increase of EpiPens from $57 to $500
Aug 23, 2016 - e! Science News
view more
 
Pfizer boosts cancer drug roster with $14B Medivation deal
Aug 23, 2016 - DailyNews724
The offer is a 55-percent premium to Sanofi SA's initial offer to buy Medivation for $52.50 in April that pushed the San Francisco-based company to put itself up for sale.
view more
 
Actavis recalls diabetes drugs made by Durham-based Patheon - Canada Standard
Aug 19, 2016 - Canada Standard
Actavis, the generic drug unit that Allergan (NYSE: AGN) recently sold to Teva Pharmaceutical Industries (NYSE: TEVA), has recalled five lots of a diabetes drug that were manufactured under a contract by Durham-based Patheon (NYSE: PTHN).
view more
 
Patent for J&J's Remicade invalidated, cheaper version looms
Aug 17, 2016 - The Western Star
view more
 
Record Increase in Patented Medicine Sales in Canada, While Pharmaceutical R&D Investment Remains at Historic Lows
Aug 17, 2016 - The Canadian Business Journal
view more
 
Solid outlook from Valeant, promised changes, fire up shares
Aug 16, 2016 - The Canadian Press
view more
 
Market Exclusivity for New Patented Drugs in Canada’s Public Drug Plans Is as Short as 3.4 Years: Canadian Health Policy Institute
Aug 16, 2016 - The Canadian Business Journal
view more
 
A copy of the Inaugural Odette World Health Innovation Network (WIN) 2015/16 Annual Report in now available on our Members Only section of our Website. This is an exciting new initiative that will be focusing on innovation in distribution.
Aug 09, 2016 -
view more

Member Forum 2022

12 septembre 2023

PLUS D’INFO

Boot Camp

19 - 20 novembre 2024
Online Event

PLUS D’INFO

Executive Conference

9 - 10 janvier 2023
Montreal Airport Marriott In-Terminal Hotel

PLUS D’INFO

Annual Conference

7 - 10 mai 2023
Sheraton Grand Nashville

PLUS D’INFO